EPM2AIP1 Antikörper (C-Term)
Kurzübersicht für EPM2AIP1 Antikörper (C-Term) (ABIN5672140)
Target
Alle EPM2AIP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human EPM2AIP1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Andere Bezeichnung
- EPM2AIP1
-
Hintergrund
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 -
Gen-ID
- 9852
-
NCBI Accession
- NM_014805, NP_055620
-
UniProt
- Q7L775
Target
-